Jesús Pintor Selected Research

Jesús Pintor Research Topics

Disease

22	Glaucoma 01/2020 - 01/2003
15	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 09/2006
8	Ocular Hypertension (Glaucoma, Suspect) 01/2020 - 01/2005
4	Achondroplasia 06/2011 - 08/2007
3	Wounds and Injuries (Trauma) 01/2022 - 06/2009
3	Inflammation (Inflammations) 09/2017 - 01/2014
2	Aniridia 11/2016 - 08/2015
2	Sjogren's Syndrome (Sjogren Syndrome) 11/2016 - 11/2010
2	Keratoconus 10/2016 - 02/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 01/2014
2	Dwarfism 06/2011 - 03/2008
1	Hypoxia (Hypoxemia) 01/2022
1	Burns 01/2022
1	Corneal Neovascularization 01/2022
1	Hyperemia 01/2020
1	Neuroinflammatory Diseases 01/2018
1	Cognitive Dysfunction 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Myopia 01/2015
1	Hypersensitivity (Allergy) 11/2014
1	Neuroblastoma 11/2014
1	Endophthalmitis (Ophthalmia) 01/2014
1	Uveitis 01/2014
1	Hyperammonemia 01/2014
1	Tauopathies 01/2014
1	Eye Diseases (Eye Disease) 03/2013
1	Optic Nerve Diseases (Optic Neuropathy) 01/2013
1	Asthma (Bronchial Asthma) 04/2010
1	Retinal Detachment (Retinal Detachments) 07/2008
1	Infections 07/2008
1	Ganglion Cysts (Ganglion) 07/2008

Drug/Important Bio-Agent (IBA)

8	MelatoninIBA 01/2020 - 12/2006
8	NucleotidesIBA 01/2018 - 01/2005
8	diadenosine tetraphosphateIBA 01/2017 - 01/2003
6	5- methoxycarbonylamino- N- acetyltryptamineIBA 10/2019 - 12/2007
6	PolyphosphatesIBA 11/2016 - 09/2006
4	Adenosine Triphosphate (ATP)IBA 01/2017 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2009
3	SecretagoguesIBA 01/2021 - 09/2016
3	MucinsIBA 01/2020 - 04/2008
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2009
3	Biomarkers (Surrogate Marker)IBA 11/2016 - 09/2006
3	Retinaldehyde (Retinal)IBA 01/2015 - 07/2008
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 11/2014
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2017
2	agomelatine (S20098)IBA 10/2019 - 02/2013
2	Purinergic P2Y2 ReceptorsIBA 01/2017 - 11/2016
2	Purinergic Receptors (Receptors, Purine)IBA 01/2017 - 01/2014
2	P(1),P(5)- di(adenosine- 5'- )pentaphosphateIBA 10/2016 - 09/2006
2	Pharmaceutical PreparationsIBA 09/2016 - 07/2013
2	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2013 - 09/2011
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 06/2011 - 03/2008
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2008 - 08/2007
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2020
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Dopamine D3 ReceptorsIBA 01/2020
1	IIK7IBA 10/2019
1	Lubricant Eye Drops (Artificial Tears)IBA 10/2019
1	Purinergic P2X7 ReceptorsIBA 01/2019
1	Purinergic P2Y ReceptorsIBA 01/2018
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2017
1	ChloridesIBA 11/2016
1	LubricantsIBA 09/2016
1	Heptanol (1 Heptanol)IBA 01/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2015
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2014
1	PyrophosphatasesIBA 11/2014
1	EnzymesIBA 01/2014
1	tau Proteins (tau Protein)IBA 01/2014
1	CF101IBA 01/2014
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2014
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2014
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2014
1	Purinergic AgonistsIBA 01/2014
1	Neuroprotective AgentsIBA 07/2013
1	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2013
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2011
1	PolymersIBA 03/2011
1	Timolol (Blocadren)FDA LinkGeneric 04/2010
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2009
1	ParasympathomimeticsIBA 05/2009
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 05/2009
1	Cholinergic AgonistsIBA 04/2008
1	Terpenes (Terpenoids)IBA 04/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2008
1	Gefarnate (Ulco)IBA 04/2008
1	cevimeline (Evoxac)FDA Link 04/2008
1	Uridine Diphosphate (UDP)IBA 01/2008
1	Adenine NucleotidesIBA 01/2005

Therapy/Procedure

3	Contact Lenses 10/2016 - 03/2013
3	Therapeutics 09/2016 - 07/2008
2	Slit Lamp 01/2022 - 01/2015
1	Topical Administration 01/2022
1	Anesthesia 01/2020
1	Refractive Surgical Procedures 11/2016
1	Lenses 02/2016
1	Laser In Situ Keratomileusis (LASIK) 01/2015